Quotes LAVA Therapeutics

Stocks

LVTX

NL0015000AG6

Biotechnology & Medical Research

Delayed Nasdaq 16:00:00 2025-11-20 EST			5-day change	1st Jan Change
1.740 ^USD	-3.87%		-.--%	-

11-21	Xoma Royalty Completes Acquisition of Lava Therapeutics	MT
11-21	Xoma Royalty announces closing of transactions to acquire LAVA Therapeutics N.V.	RE

Stock exchange

Nasdaq LVTX 1.740 $ -3.87% 497K $

Performance

1 day	-3.87%
1 year	+12.26%
3 years	+4.19%
5 years	-70.36%

Volumes

markets

Daily volume

285,521

Estimated daily volume

285,521

Record volume 1

44,648,010

Record volume 2

43,378,213

Record volume 3

36,886,664

Capital turnover ratio

Float rotation

Basic data

Market Cap (USD)

45,771,213

Net sales ()

Number of employees

Sales / Employee ()

Sales / Employee (USD)

Free-Float

83.62 %

Free-Float capitalization (USD)

38,271,634

Indicators

Moving average 5 days

1.748

Moving average 100 days

1.538

Price spread / (MMA5)

+0.43%

Price spread / (MMA100)

-11.60%

STIM

RSI 9 days

RSI 14 days

Sector Comparison:

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
LAVA THERAPEUTICS	-3.87%	-.--%	+12.26%	+4.19%	45.77M
LONZA GROUP AG	-3.24%	-7.78%	-5.35%	+10.43%	48.01B
REVOLUTION MEDICINES, INC.	+0.88%	-0.22%	+409.93%	+535.12%	44.44B
IQVIA HOLDINGS INC.	-1.04%	-3.12%	+34.79%	+18.71%	42.67B
BEONE MEDICINES AG	-0.52%	-3.29%	-0.36%	+67.21%	39.96B
CELLTRION, INC.	0.00%	-2.61%	+13.09%	+42.33%	32.75B
ASCENDIS PHARMA A/S	-2.71%	-1.70%	-	-	17.74B
MEDPACE HOLDINGS, INC.	-1.44%	-2.14%	+19.51%	+107.74%	16.49B
EUROFINS SCIENTIFIC SE	-0.37%	-2.53%	+10.91%	+30.93%	14.38B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-1.19%	-5.02%	+76.08%	+38.80%	13.4B
Average	-1.33%	-0.48%	+63.43%	+95.05%	26.99B
Weighted average by Cap.	-0.97%	-1.10%	+84.70%	+126.48%